Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03844256 |
| Title | A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study (CRIMI) |
| Acronym | CRIMI |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | NLD |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Amsterdam UMC, VUmc | RECRUITING | Amsterdam | Noord-Holland | 1081 HV | Netherlands | Details |
| Amsterdam UMC, AMC | RECRUITING | Amsterdam | Noord-Holland | 1105 AZ | Netherlands | Details |
| LUMC | RECRUITING | Leiden | Zuid-Holland | Netherlands | Details |